Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

BioCryst Pharmaceuticals, Inc. BCRX

Set alert

Price alert · BCRX

All alert types
8.25 USD -0.23 -2.66%

At close

8.16 -0.08 -1.03%

Pre-market · Nov 3, 8:10 AM ET

Bid
8.24 × 1
Ask
8.25 × 1
8.22 Day range 8.52
6.23 52-week range 11.22
YTD
+5.71%
1 year
+12.64%
Open
8.49
Prev close
8.47
Mkt cap
2.11B
Vol
4.09M
Avg vol
4.61M
EPS
-1.36
P/E
0.00
Div yield
0.00%
More statistics
Low
8.22
High
8.52
Forward P/E
9.99
Beta
0.51
Short ratio
4.97
Inst. own
105.87%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
8.63
200-d avg
8.75
1y target
20.55

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Apr 2, 2014Dividend: 0
  • Jun 5, 2014Dividend: 0
  • Aug 4, 2025Earnings: 0.02; estimate 0.03; surprise -33.33%
  • Nov 3, 2025Earnings: 0.06; estimate 0.07; surprise -14.29%
  • May 6, 2026Earnings: -2.98; estimate 0.06; surprise -5066.67%
  • Jul 7, 2026Rating: RBC Capital · Outperform → Outperform
  • Aug 5, 2026Earnings: 0.3; estimate 0.1542; surprise 94.55%
  • Aug 6, 2026Rating: Wedbush · Outperform → Outperform
  • Aug 6, 2026Rating: RBC Capital · Outperform → Outperform
  • Nov 4, 2026Earnings: —; estimate 0.09186; surprise —%
Signals (125)
NameDateAgo
SMA: BearishNov 2, 202619 hours ago
MACD: Sell SignalNov 2, 202619 hours ago
SMA: BearishSep 1, 20262 months ago
SMA: BullishFeb 1, 20269 months ago
SMA: BullishFeb 1, 20269 months ago
MACD: Buy SignalFeb 1, 20269 months ago
SMA: BearishJan 1, 202610 months ago
SMA: BullishDec 1, 202511 months ago
SMA: BearishNov 1, 20251 year ago
MACD: Sell SignalNov 1, 20251 year ago
SMA: BearishJul 1, 20251 year ago
SMA: BullishApr 1, 20251 year ago
SMA: BullishApr 1, 20251 year ago
SMA: BearishMar 1, 20251 year ago
SMA: BearishMar 1, 20251 year ago
SMA: BullishFeb 1, 20251 year ago
SMA: BearishSep 1, 20242 years ago
SMA: BullishAug 1, 20242 years ago
MACD: Buy SignalJul 1, 20242 years ago
SMA: BullishMay 1, 20242 years ago

Newest 20 of 125.

Financial health

Altman Z-Score

-3.69 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 5
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E 6.2×
FY 2016: -8.4×FY 2017: -6.3×FY 2018: -8.2×FY 2019: -3.7×FY 2020: -6.8×FY 2021: -13.4×FY 2022: -8.6×FY 2023: -5.1×FY 2024: -17.5×FY 2025: 6.2×
FY 2016 5y median -8.6× FY 2025
P/S 1.9×
FY 2016: 17.7×FY 2017: 16.5×FY 2018: 40.3×FY 2019: 8.2×FY 2020: 70.0×FY 2021: 15.8×FY 2022: 7.9×FY 2023: 3.5×FY 2024: 3.4×FY 2025: 1.9×
FY 2016 5y median 3.5× FY 2025
P/B -13.7×
FY 2016: -0.8×FY 2017: -0.7×FY 2018: -1.1×FY 2019: 10.4×FY 2020: -64.7×FY 2021: -23.2×FY 2022: -7.2×FY 2023: -2.5×FY 2024: -3.3×FY 2025: -13.7×
FY 2016 5y median -7.2× FY 2025
P/FCF 5.0×
FY 2016: -7.9×FY 2017: -10.0×FY 2018: -9.0×FY 2019: -4.4×FY 2020: -9.0×FY 2021: -17.2×FY 2022: -13.1×FY 2023: -11.8×FY 2024: -29.2×FY 2025: 5.0×
FY 2016 5y median -13.1× FY 2025
EV/EBITDA 5.7×
FY 2016: -10.3×FY 2017: -7.4×FY 2018: -9.6×FY 2019: -3.8×FY 2020: -7.5×FY 2021: -21.1×FY 2022: -17.9×FY 2023: -16.0×FY 2024: 179×FY 2025: 5.7×
FY 2016 5y median -16.0× FY 2025
EV/Sales 2.3×
FY 2016: 18.9×FY 2017: 16.6×FY 2018: 42.0×FY 2019: 7.6×FY 2020: 70.4×FY 2021: 16.3×FY 2022: 9.5×FY 2023: 5.6×FY 2024: 5.1×FY 2025: 2.3×
FY 2016 5y median 5.6× FY 2025
FCF Yield 20.0%
FY 2016: -12.6%FY 2017: -10.0%FY 2018: -11.2%FY 2019: -22.5%FY 2020: -11.1%FY 2021: -5.8%FY 2022: -7.6%FY 2023: -8.5%FY 2024: -3.4%FY 2025: 20.0%
FY 2016 5y median -5.8% FY 2025

Profitability

Gross Margin 97.8%
FY 2016: 89.8%FY 2017: 93.2%FY 2018: 97.7%FY 2019: 91.6%FY 2020: 90.6%FY 2021: 95.4%FY 2022: 97.6%FY 2023: 98.6%FY 2024: 97.2%FY 2025: 97.8%
FY 2016 5y median 97.6% FY 2025
Operating Margin 39.0%
FY 2016: -184.4%FY 2017: -227.9%FY 2018: -456.2%FY 2019: -203.7%FY 2020: -981.1%FY 2021: -113.1%FY 2022: -54.8%FY 2023: -31.3%FY 2024: -0.6%FY 2025: 39.0%
FY 2016 5y median -31.3% FY 2025
Net Margin 30.2%
FY 2016: -209.3%FY 2017: -261.2%FY 2018: -490.3%FY 2019: -223.0%FY 2020: -1026.4%FY 2021: -117.1%FY 2022: -91.2%FY 2023: -68.4%FY 2024: -19.7%FY 2025: 30.2%
FY 2016 5y median -68.4% FY 2025
ROE -221.4%
FY 2016: 9.7%FY 2017: 10.4%FY 2018: 13.8%FY 2019: -284.7%FY 2020: 949.1%FY 2021: 172.0%FY 2022: 83.9%FY 2023: 49.7%FY 2024: 18.7%FY 2025: -221.4%
FY 2016 5y median 49.7% FY 2025
ROIC 105.2%
FY 2016: -76.3%FY 2017: -41.4%FY 2018: -84.8%FY 2019: -80.9%FY 2020: -67.2%FY 2021: -36.5%FY 2022: -33.2%FY 2023: -28.1%FY 2024: -0.7%FY 2025: 105.2%
FY 2016 5y median -28.1% FY 2025
ROA 51.3%
FY 2016: -61.4%FY 2017: -36.9%FY 2018: -69.0%FY 2019: -62.1%FY 2020: -54.6%FY 2021: -31.3%FY 2022: -44.9%FY 2023: -43.8%FY 2024: -18.1%FY 2025: 51.3%
FY 2016 5y median -31.3% FY 2025

Growth (YoY)

Revenue 94.1%
FY 2016: -45.4%FY 2017: -4.4%FY 2018: -18.0%FY 2019: 136.5%FY 2020: -63.5%FY 2021: 782.4%FY 2022: 72.3%FY 2023: 22.4%FY 2024: 36.0%FY 2025: 94.1%
FY 2016 FY 2025
Operating Income 13508.9%
FY 2016: -23.2%FY 2017: -18.1%FY 2018: -64.1%FY 2019: -5.6%FY 2020: -75.7%FY 2021: -1.7%FY 2022: 16.5%FY 2023: 30.1%FY 2024: 97.5%FY 2025: 13508.9%
FY 2016 FY 2025
EPS (diluted) 381.4%
FY 2016: -27.1%FY 2017: -4.0%FY 2018: -25.6%FY 2019: 4.1%FY 2020: -16.0%FY 2021: 5.5%FY 2022: -29.1%FY 2023: 11.3%FY 2024: 63.6%FY 2025: 381.4%
FY 2016 FY 2025
Free Cash Flow 716.1%
FY 2016: -221.9%FY 2017: 29.4%FY 2018: -124.1%FY 2019: 3.2%FY 2020: -53.2%FY 2021: -4.9%FY 2022: -12.9%FY 2023: 40.4%FY 2024: 45.4%FY 2025: 716.1%
FY 2016 FY 2025

Financial Health

Current Ratio 2.1×
FY 2016: 1.2×FY 2017: 1.7×FY 2018: 1.6×FY 2019: 1.8×FY 2020: 3.1×FY 2021: 5.5×FY 2022: 4.9×FY 2023: 3.3×FY 2024: 2.6×FY 2025: 2.1×
FY 2016 5y median 3.3× FY 2025
Quick Ratio 2.0×
FY 2016: 1.2×FY 2017: 2.2×FY 2018: 1.6×FY 2019: 1.8×FY 2020: 3.0×FY 2021: 5.3×FY 2022: 4.6×FY 2023: 3.1×FY 2024: 2.6×FY 2025: 2.0×
FY 2016 5y median 3.1× FY 2025
Debt / Equity -3.7×
FY 2016: -0.1×FY 2017: -0.1×FY 2018: -0.1×FY 2019: 2.2×FY 2020: -14.5×FY 2021: -5.5×FY 2022: -2.5×FY 2023: -1.8×FY 2024: -1.8×FY 2025: -3.7×
FY 2016 5y median -2.5× FY 2025
Net Debt / EBITDA 1.0×
FY 2016: -0.7×FY 2017: -0.1×FY 2018: -0.4×FY 2019: 0.3×FY 2020: -0.0×FY 2021: -0.7×FY 2022: -3.0×FY 2023: -6.1×FY 2024: 57.5×FY 2025: 1.0×
FY 2016 5y median -0.7× FY 2025
Interest Coverage 4.3×
FY 2016: -7.5×FY 2017: -6.7×FY 2018: -10.3×FY 2019: -8.4×FY 2020: -12.1×FY 2021: -3.0×FY 2022: -1.5×FY 2023: -1.0×FY 2024: -0.0×FY 2025: 4.3×
FY 2016 5y median -1.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31